Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect …

JJM Van Dongen, AW Langerak, M Brüggemann… - Leukemia, 2003 - nature.com
In a European BIOMED-2 collaborative study, multiplex PCR assays have successfully been
developed and standardized for the detection of clonally rearranged immunoglobulin (Ig) …

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects

VHJ Van der Velden, A Hochhaus, G Cazzaniga… - Leukemia, 2003 - nature.com
Detection of minimal residual disease (MRD) has prognostic value in many hematologic
malignancies, including acute lymphoblastic leukemia, acute myeloid leukemia, chronic …

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

JJM van Dongen, T Seriu, ER Panzer-Grümayer… - The Lancet, 1998 - thelancet.com
Background Sensitive techniques for detection of minimal residual disease (MRD) at
degrees of one leukaemic cell per 10 3–10 6 cells (10− 3–10− 6) during follow-up of …

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia

H Cavé, J van der Werff Ten Bosch… - … England Journal of …, 1998 - Mass Medical Soc
Background and Methods The implications of the detection of residual disease after
treatment of acute lymphoblastic leukemia (ALL) are unclear. We conducted a prospective …

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 …

M Brüggemann, A Schrauder, T Raff, H Pfeifer… - Leukemia, 2010 - nature.com
Assessment of minimal residual disease (MRD) has acquired a prominent position in
European treatment protocols for patients with acute lymphoblastic leukemia (ALL), on the …

Childhood leukemias

CH Pui - New England Journal of Medicine, 1995 - Mass Medical Soc
The childhood leukemias are a study in contrasts. Acute lymphoblastic leukemia (ALL) is
diagnosed in approximately 2000 children in the United States each year, whereas acute …

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

E Coustan-Smith, FG Behm, J Sanchez, JM Boyett… - The Lancet, 1998 - thelancet.com
Background The clinical significance of submicroscopic levels of leukaemic cells in bone-
marrow aspirates from children with acute lymphoblastic leukaemia (ALL) remains …

T-cell repertoire diversity and clonal expansions in normal and clinical samples

C Pannetier, J Even, P Kourilsky - Immunology today, 1995 - cell.com
Christophe Pannetier, Jos Even and Philippe Kourilsky lmproved polymerase chailr reaction
(RX)-based methods now permit a mare in-depth analysis of the repertoire of T cells …

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

MJ Pongers-Willemse, O Verhagen, GJM Tibbe… - Leukemia, 1998 - nature.com
Abstract Analysis of minimal residual disease (MRD) can predict outcome in acute
lymphoblastic leukemia (ALL). A large prospective study in childhood ALL has shown that …

Molecular detection of micrometastases and circulating tumor cells in solid tumors

RA Ghossein, S Bhattacharya, J Rosai - Clinical Cancer Research, 1999 - AACR
The detection of circulating tumor cells and micrometastases may have important prognostic
and therapeutic implications. Because their numbers can be very small, these tumor cells …